Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/s41375-025-02652-0.

Title:
T cell receptor mimic CAR T cells targeting cathepsin G signal peptide | Leukemia
Description:
There has been a been a paucity of immunotherapy targets in myeloid malignancies. We identified the HLA-A2 (A2)-restricted, cathepsin G (CG)-derived signal peptide, CG1, as a promising immunotherapeutic target. CG1 is presented by HLA-A2 in acute (AML) and chronic (CML) myeloid leukemia. We previously developed a T cell receptor-mimic antibody (TCR-m) that targets CG1/A2, engineered it into a bispecific T cell engager antibody, and demonstrated its safety and efficacy in AML and CML. In this study, we provide data for the engineering, preclinical efficacy, and safety of CG1/A2-targeting chimeric antigen receptor (CAR) T cells (CG1/A2-CAR T), which utilize the CG1/A2 TCR-m constructs. We show that the CG1/A2 TCR-m has high affinity for CG1/A2 monomers and CG1/A2-expressing leukemia, including HLA-A2+ AML and CML. We demonstrate potent CG1/A2 CAR T killing of HLA-A2+ AML and CML both in vitro and in vivo. Importantly, we found that CG1/A2-CAR T cells did not affect normal bone marrow hematopoiesis. These results validate signal peptides as immunotherapeutic targets and provide a foundation for the continued clinical development of CG1/A2-CAR T cells in AML and CML.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Education
  • Science
  • Telecommunications

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

πŸŒ† Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$536,300 per month
Our estimates place Nature.com's monthly online earnings from display ads at $357,503 to $983,134.

Keywords {πŸ”}

pubmed, article, google, scholar, cas, leukemia, central, cells, cancer, nature, cell, myeloid, acute, car, antigen, data, cathepsin, alatrash, med, immunotherapy, immunol, tcell, sukhumalchandra, zhang, access, therapy, figure, supplementary, targeting, aml, research, content, receptor, john, antibody, human, cookies, peptide, yan, jeffrey, molldrem, hlaa, res, blood, relapsed, nat, privacy, information, signal, shi,

Topics {βœ’οΈ}

nature portfolio anti-pr1/hla-a2 t-cell receptor privacy policy editing advertising signal sequence-derived peptides figure preparation laboratory research guidelines involve direct research anti-pr1/hla-a2 antibody nature social media administering leukemia-specific donor cell receptor-mimic antibody continued clinical development specific peptide/hla class reprints fc-mediated effector functions mediate anti-leukemia activity car t-cell activity myeloid leukemia-specific cd4 anti-cll1 based car holds exclusive rights human tcr-binding affinity b-cell lymphoblastic leukemia clathrin pit-mediated endocytosis nod/ltsz-scid mice derived signal peptide research iacuc-approved animal protocol antigen-processing mutant cell publishing agreement springerlink instant access t-cell receptor t-cell receptor tap-independent mhc class chimeric antigen receptor cg1/a2-expressing leukemia stem cell transplantation development including hla-a2+ aml permissions t-cell subsets unicar-t-cd123 antigen density requirement chimeric antigen receptors cole dk hematopoietic cell transplantation cell engager antibody pr1-targeted immunotherapy

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:T cell receptor mimic CAR T cells targeting cathepsin G signal peptide
         description:There has been a been a paucity of immunotherapy targets in myeloid malignancies. We identified the HLA-A2 (A2)-restricted, cathepsin G (CG)-derived signal peptide, CG1, as a promising immunotherapeutic target. CG1 is presented by HLA-A2 in acute (AML) and chronic (CML) myeloid leukemia. We previously developed a T cell receptor-mimic antibody (TCR-m) that targets CG1/A2, engineered it into a bispecific T cell engager antibody, and demonstrated its safety and efficacy in AML and CML. In this study, we provide data for the engineering, preclinical efficacy, and safety of CG1/A2-targeting chimeric antigen receptor (CAR) T cells (CG1/A2-CAR T), which utilize the CG1/A2 TCR-m constructs. We show that the CG1/A2 TCR-m has high affinity for CG1/A2 monomers and CG1/A2-expressing leukemia, including HLA-A2+ AML and CML. We demonstrate potent CG1/A2 CAR T killing of HLA-A2+ AML and CML both in vitro and in vivo. Importantly, we found that CG1/A2-CAR T cells did not affect normal bone marrow hematopoiesis. These results validate signal peptides as immunotherapeutic targets and provide a foundation for the continued clinical development of CG1/A2-CAR T cells in AML and CML.
         datePublished:2025-05-28T00:00:00Z
         dateModified:2025-05-28T00:00:00Z
         pageStart:1
         pageEnd:12
         sameAs:https://doi.org/10.1038/s41375-025-02652-0
         keywords:
            Acute myeloid leukaemia
            Cancer immunotherapy
            Immunotherapy
            Preclinical research
            Medicine/Public Health
            general
            Internal Medicine
            Intensive / Critical Care Medicine
            Cancer Research
            Oncology
            Hematology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig8_HTML.png
         isPartOf:
            name:Leukemia
            issn:
               1476-5551
               0887-6924
            type:
               Periodical
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jun Yan
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chunhua Shi
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guojun Yang
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ze Tian
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiroki Torikai
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pariya Sukhumalchandra
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shaohua Peng
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Edward Chang
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Meng Cui
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Celine Kerros
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anne Philips
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Na Qiao
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mao Zhang
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Timothy E. Lofton
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jason K. Allen
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michelle A. Gonzalez
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sathvik Patchametla
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anna Sergeeva
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lisa St. John
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Helen He
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dongxing Zha
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeffrey Molldrem
               url:http://orcid.org/0000-0003-1196-1715
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Gheath Alatrash
               url:http://orcid.org/0000-0002-7648-4377
               affiliation:
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:T cell receptor mimic CAR T cells targeting cathepsin G signal peptide
      description:There has been a been a paucity of immunotherapy targets in myeloid malignancies. We identified the HLA-A2 (A2)-restricted, cathepsin G (CG)-derived signal peptide, CG1, as a promising immunotherapeutic target. CG1 is presented by HLA-A2 in acute (AML) and chronic (CML) myeloid leukemia. We previously developed a T cell receptor-mimic antibody (TCR-m) that targets CG1/A2, engineered it into a bispecific T cell engager antibody, and demonstrated its safety and efficacy in AML and CML. In this study, we provide data for the engineering, preclinical efficacy, and safety of CG1/A2-targeting chimeric antigen receptor (CAR) T cells (CG1/A2-CAR T), which utilize the CG1/A2 TCR-m constructs. We show that the CG1/A2 TCR-m has high affinity for CG1/A2 monomers and CG1/A2-expressing leukemia, including HLA-A2+ AML and CML. We demonstrate potent CG1/A2 CAR T killing of HLA-A2+ AML and CML both in vitro and in vivo. Importantly, we found that CG1/A2-CAR T cells did not affect normal bone marrow hematopoiesis. These results validate signal peptides as immunotherapeutic targets and provide a foundation for the continued clinical development of CG1/A2-CAR T cells in AML and CML.
      datePublished:2025-05-28T00:00:00Z
      dateModified:2025-05-28T00:00:00Z
      pageStart:1
      pageEnd:12
      sameAs:https://doi.org/10.1038/s41375-025-02652-0
      keywords:
         Acute myeloid leukaemia
         Cancer immunotherapy
         Immunotherapy
         Preclinical research
         Medicine/Public Health
         general
         Internal Medicine
         Intensive / Critical Care Medicine
         Cancer Research
         Oncology
         Hematology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41375-025-02652-0/MediaObjects/41375_2025_2652_Fig8_HTML.png
      isPartOf:
         name:Leukemia
         issn:
            1476-5551
            0887-6924
         type:
            Periodical
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jun Yan
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chunhua Shi
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guojun Yang
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ze Tian
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiroki Torikai
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pariya Sukhumalchandra
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shaohua Peng
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Edward Chang
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Meng Cui
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Celine Kerros
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anne Philips
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Na Qiao
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mao Zhang
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Timothy E. Lofton
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jason K. Allen
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michelle A. Gonzalez
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sathvik Patchametla
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anna Sergeeva
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lisa St. John
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Helen He
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dongxing Zha
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeffrey Molldrem
            url:http://orcid.org/0000-0003-1196-1715
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Gheath Alatrash
            url:http://orcid.org/0000-0002-7648-4377
            affiliation:
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical"]:
      name:Leukemia
      issn:
         1476-5551
         0887-6924
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:University of Texas MD Anderson Cancer Center
      address:
         name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jun Yan
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Chunhua Shi
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Guojun Yang
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Ze Tian
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Hiroki Torikai
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Pariya Sukhumalchandra
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Shaohua Peng
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Edward Chang
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Meng Cui
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Celine Kerros
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Anne Philips
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Na Qiao
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Mao Zhang
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Timothy E. Lofton
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Jason K. Allen
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Michelle A. Gonzalez
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Sathvik Patchametla
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Anna Sergeeva
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Lisa St. John
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Helen He
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Dongxing Zha
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Jeffrey Molldrem
      url:http://orcid.org/0000-0003-1196-1715
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Gheath Alatrash
      url:http://orcid.org/0000-0002-7648-4377
      affiliation:
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:University of Texas MD Anderson Cancer Center
            address:
               name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Oncology Research for Biologics and Immunotherapy Translation (ORBIT), University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Hematopoietic Biology and Malignancy, University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {πŸ‘}(1)

External Links {πŸ”—}(262)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.25s.